Advertisement
Home »

Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell Lung Cancer through miR-181a-3p/UPR-ERAD Axis.

Feb 05, 2024

ABOUT THE EXPERTS

  • Lihuai Wang

    Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.

    Tonglin Sun

    Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.

    Xiao Yang

    Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.

    Zhi Wen

    Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.

    Yinhui Sun

    Department of Pathophysiology, Medical College, Hunan University of Traditional Chinese Medicine, Changsha 410208, Hunan Province, China.

    Hua Liu

    Department of Oncology, the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, Hunan Province, China.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement